pipette
ESEspañol

A multi-scale cell-type resolved map of trans-regulatory architecture in the aging human brain

X. Cao, Y. Wang, H. Sun, R. Feng, H. Zhang, Y. Li, H. Lee, B. Karaahmet, B. Li, C. Gersbach, G. E. Crawford, M. Taga, M. S. Beeri, A. S. Buchman, H.-U. Klein, P. De Jager, D. A. Bennett, The Alzheimer's Disease Functional Genomics Consortium, G. Wang, K. K. Dey

Preprint

In the authors' words

Mapping genetic effects on distal genes and regulatory programs is essential for understanding how genetic variation influences complex diseases; yet trans-QTL discovery remains limited by weak effect sizes, extensive multiple testing and poor reproducibility. Here, we introduce TransMap, a generalizable computational framework that combines multi-scale trans-QTL mapping with multi-phenotype genetic colocalization to improve the discovery and interpretation of distal regulatory variants. Beyond individual trans-eGenes, TransMap constructs local co-regulatory program phenotypes that account for background expression variation to improve the detection of weak, coordinated distal genetic effects. Across a broad range of simulation settings, TransMap achieved 9.2-36.7% higher trans-QTL discovery power than existing methods while maintaining well-controlled type I error rates. We applied TransMap to bulk and single-nucleus transcriptomic profiles from the aging human brain in the ADSP Functional Genomics Consortium (FunGen-AD), further integrating proteomic, glycoproteomic and metabolomic biomarker measurements (average N=476 donors). Genome-wide fine-mapping of TransMap single-gene and program-level QTL yielded variant annotations with 2.75-2.88x heritability enrichment across 57 complex diseases and traits (average N=307K), with complementary heritability information captured across regulatory scales. Multi-phenotype colocalization identified 49,532 trans-regulatory events supported by shared genetic signals with cis-eQTL or biomarker-QTL, including 1,825 candidate cis-trans-biomarker regulatory configurations. TransMap further revealed an asymmetric cross-cell-type regulatory architecture in which neuronal cis-regulatory signals preferentially associate with coordinated glial trans-regulatory responses, supported by co-culture experiments and spatial transcriptomics. Alzheimer's disease (AD) GWAS-prioritized colocalization identified trans-regulatory associations in 115 AD-associated loci, including a KNOP1 cis-eQTL associated in trans with a microglial regulatory program containing MS4A4E, with additional support from statistical mediation analysis. TransMap provides a multi-scale, cell-type-resolved atlas of trans-regulatory variation and a generalizable framework for elucidating the regulatory architecture of complex diseases.

Main resultThe abstract does not state a limitation.

In plain words AI summary

The authors created TransMap, a new computational tool that finds distant genetic variants affecting gene regulation. TransMap detects weak coordinated effects by grouping genes into local co-regulatory programs. In simulations, TransMap found 9.2-36.7% more distant regulatory variants than existing methods. Applied to aging human brain data from 476 donors, the tool revealed 49,532 distant regulatory events. The study found that neuron signals preferentially trigger coordinated responses in glial cells.

Written by Kimi K2.5 using only the abstract above. Jev checked that every sentence is supported by the abstract sentences it cites, and removed any that were not. Point at a sentence to highlight its source.

Appeared: Monday, November 9. medRxiv. Preprint, not yet peer-reviewed.

DOI: 10.64898/2026.11.05.26367384